Group A (FIT): Avapritinib + IA regimen
SZ-AML03
Phase 2 small_molecule active
Quick answer
Group A (FIT): Avapritinib + IA regimen for Acute Myeloid Leukemia With T(8;21)(Q22;Q22) is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active